Revatis S.A. • Mission, values & team Revatis aims to be a benchmark player in cell therapy and regenerative medicine

“One of the few companies in the world with a patented technique for the collection and production of stem cells”

Didier Serteyn

Revatis has developed an innovative process to sample, isolate, differentiate and culture stem cells. These cells are characterized, available in sufficient quantity and express characteristics useful for R&D and clinical developments.

Innovation and creativity

Revatis relies on the scientific publications of a dynamic team and has a solid and evolving patent portfolio.

Innovation and creativity

Vision and perspective

Revatis has a clear and reasoned approach to the potential of its technology in research and in the clinic and develops partnerships with renowned research centers and downstream companies.

Vision and perspective

Quality an security

Revatis produces stem cells in a GMP certified aseptic isolator for batch production of cells for R&D and clinical applications.

Quality an security

Our team

Didier Serteyn

CEO

Didier Serteyn

Jean-Philippe Lejeune

Business Development

Jean-Philippe Lejeune

Justine Ceusters

CSO/COO

Justine Ceusters

Alison Fraikin

Supply Chain Associate

Alison Fraikin

Jean-Luc Martin

CFO

Jean-Luc Martin

Significant contribution in cell therapy and regenerative medicine

R&D programs, preclinical and clinical studies bring a new dimension in personalized veterinary and human medicine.